Upon activation, naïve CD8+ T cells proliferate and differentiate to generate effector CD8+ T cells, which, in turn, synthesize copious amounts of cytotoxic effector molecules (Granzyme B and Perforin) and inflammatory cytokines (IFN-γ and TNF-α) that kill tumor cells [16]. The gene discussed is CD8A; the disease is neoplasm.